Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $167.89M.
ENTERPRISE VALUE (EV)
$167.89M
OptimizeRx Corp.
Market Cap
$165.58M
Enterprise Value (EV)
$167.89M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| OptimizeRx Corp. (OPRX) | $165.58M | $167.89M |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | $119.33M |
| Quanterix Corporation (QTRX)vs › | $164.16M | $153.38M |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | $190.70M |
| PepGen Inc. (PEPG)vs › | $162.20M | $155.53M |
| MediWound Ltd. (MDWD)vs › | $170.85M | $176.04M |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | $54.57M |
| Cue Biopharma, Inc. (CUE)vs › | $173.26M | $164.67M |
| Nkarta, Inc. (NKTX)vs › | $173.50M | $222.08M |
| Precision BioSciences, Inc. (DTIL)vs › | $173.75M | $115.78M |
Market Cap
$165.58M
Total Debt
$25.68M
Cash
$23.36M
Enterprise Value
$167.89M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
